Christopher C. Lemasters - Net Worth and Insider Trading

Christopher C. Lemasters Net Worth

The estimated net worth of Christopher C. Lemasters is at least $0 dollars as of 2024-11-13. Christopher C. Lemasters is the EVP, Chief Business Officer of Mirati Therapeutics Inc and owns about 0 shares of Mirati Therapeutics Inc (MRTX) stock worth over $0. Details can be seen in Christopher C. Lemasters's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher C. Lemasters has not made any transactions after 2019-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Christopher C. Lemasters

Christopher C. Lemasters Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher C. Lemasters owns 1 companies in total, including Mirati Therapeutics Inc (MRTX) .

Click here to see the complete history of Christopher C. Lemasters’s form 4 insider trades.

Insider Ownership Summary of Christopher C. Lemasters

Ticker	Comapny	Transaction Date	Type of Owner
MRTX	Mirati Therapeutics Inc	2019-02-14	EVP & CHIEF BUSINESS OFFICER

Christopher C. Lemasters Latest Holdings Summary

Christopher C. Lemasters currently owns a total of 1 stock. Christopher C. Lemasters owns 0 shares of Mirati Therapeutics Inc (MRTX) as of February 14, 2019, with a value of $0.

Latest Holdings of Christopher C. Lemasters

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MRTX	Mirati Therapeutics Inc	2019-02-14	0	58.70	0

Holding Weightings of Christopher C. Lemasters

Christopher C. Lemasters Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher C. Lemasters has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 60,000 shares on February 14, 2019, which brought Christopher C. Lemasters around $4 Million.

Insider Trading History of Christopher C. Lemasters

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher C. Lemasters Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher C. Lemasters Ownership Network

Ownership Network List of Christopher C. Lemasters

No Data

Ownership Network Relation of Christopher C. Lemasters

Christopher C. Lemasters Owned Company Details

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Christopher C. Lemasters is the EVP & CHIEF BUSINESS OFFICER of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , EVP & Chief Commercial Officer Benjamin Hickey , and Interim CFO Aaron Ondrey .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

Over the past 18 months, Christopher C. Lemasters made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 8,522 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,076 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,509,661 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirati Therapeutics Inc Insider Transactions

No Available Data

Christopher C. Lemasters Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher C. Lemasters. You might contact Christopher C. Lemasters via mailing address: C/o Mirati Therapeutics, Inc., 9393 Towne Centre Drive, Suite 200, San Diego Ca 92121.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.